Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Search

News

The German Association for Certification has confirmed that Ascenion complies with the quality management system requirements of European norm DIN EN…

Don’t miss your chance to secure a spot at next year’s BioVaria, 27 – 28 April 2020 in Munich! Application for European startups is now open until 14t…

The NUVISAN group, an international service provider for clinical studies, contract development and manufacturing (CRO/CDMO) with headquarters in…

Ascenion welcomes a new colleague to the Munich office: Jennifer Clayton-Chen joined the company as Legal Counsel in September 2019. Her main…

[Translate to English:]

Ascenion’s portfolio company Photonion GmbH offers innovative mass spectrometry systems that allow a more detailed analysis of air pollutants,…

[Translate to English:]

Learn about the milestones we reached together with our partners in 2018, the revenues we generated and interesting emerging trends. The key points at…

Should public research institutes and universities receive equity in start-ups founded to commercialize their intellectual property? And if so, how…

New website online

Check out our new website design to help you find what you need:
 

  • Information about us and our services
  • Technology offers from our partner…
[Translate to English:]

New drug delivery system to enable needle-free application of drugs

More than 1,300 delegates from 35+ countries, such as big pharma, emerging and small biotech, diagnostics companies, pre-seed, seed and Series-A…

Confidential disclosure agreements, material transfer agreements and term sheets – all these contracts have to be closed during the planning phase of…

This year’s innovation prize from the Metropolregion Mitteldeutschland goes to a team that has brought a novel anti-tuberculosis compound all the way…

Be part of Munich’s vibrant bioentrepreneurial ecosystem and join the BioEntrepreneurship Summit on 15 – 16 October 2019. The event is organized by…

[Translate to English:]

Dr Manal Chatila-Schiffer joined Ascenion in April 2019 to support the team in business and technology development. She draws on dedicated expertise…

Ascenion’s portfolio company Berlin Cures has initiated a Phase IIa clinical study with its lead compound BC 007. The two-armed, randomized,…

Events